Table 3.

Classification results from leave-one-out cross-validation on urine samples from patients with prostate cancer and patients with haematuria and or prostatic symptoms. LDA = linear discriminant analysis; and SVM-P = support vector machine.

Linear discriminant analysis (LDA)
	Prostate cancer	Control
Prostate cancer	54	4	Sensitivity =	93.1%
Control	3	70	Specificity =	95.9%
Support vector machine polynomial (SVM-P)
	Prostate cancer	Control
Prostate cancer	55	3	Sensitivity =	94.8%
Control	3	70	Specificity =	95.9%